Email Updates

You are here

AVAC in the News

  • The failure of a daily pill to protect healthy African women against AIDS may not have been the pill’s fault but the women’s reluctance to take it, scientists at an important AIDS conference in Seattle were told this week.

    March 12, 2012
    New York Times
  • Scientists are scrutinizing a new approach to preventing the spread of HIV that involves healthy people taking drugs to keep them from being infected by partners with the virus that causes AIDS.

    March 7, 2012
    Wall Street Journal
  • The day of the assembly-line circumcision is drawing closer.

    January 30, 2012
    New York Times
  • The journal Science has named an AIDS study as its 2011 Breakthrough of the Year. The clinical trial found that antiretroviral drugs can be used to dramatically lower the risk of transmitting HIV. The clinical trial is known as HPTN 052. It proved that giving the drugs to HIV infected people sooner made them 96 percent less likely to transmit the virus to their uninfected partners.

    December 28, 2011
    Voice of America
  • In the nearly 30 years the AIDS epidemic has raged, there has never been a more hopeful day than this. Three striking developments took place Tuesday: U.N. officials said new HIV cases are dropping dramatically worldwide. A study showed that a daily pill already on pharmacy shelves could help prevent new infections in gay men. And the pope opened the way for the use of condoms to prevent AIDS.

    December 26, 2011
    Brattleboro Reformer
  • US regulators are to consider a groundbreaking – but potentially controversial – new application to use an HIV medicine as a way to prevent healthy people from becoming infected with the lethal virus.

    December 16, 2011
    Financial Times
  • Treatment activists from ACT UP New York founded AVAC in 1995 to speed up the development of HIV vaccines. Today, AVAC also has its sights set on biomedical HIV prevention (like microbicides , PrEP and treatment as prevention), treatment for genital herpes (HSV-2) and the protective powers of male circumcision and cervical barriers. CEO Mitchell Warren is an outspoken advocate who writes regularly in the Huffington Post about the power of prevention. He was one of the first out of the gate this year to publicy tout the “we can end AIDS” beat.

    December 1, 2011
  • A curious emotional amalgam marked this year's World AIDS Day. On one hand, there is increasing confidence that many of the tools needed to halt the devastating pandemic are either available or will soon be ready. On the other, there is growing fear that the political and financial will to use those tools is failing.

    December 1, 2011
    MedPage Today
  • There are growing calls to integrate HIV prevention and treatment programmes with family planning and other health services, yet a recent study has sparked concern that the two may interact in dangerous ways.

    November 30, 2011
    Financial Times
  • A leading AIDS advocacy group says while the end of the HIV/AIDS epidemic is within reach, success is far from assured. AVAC has released a science-based agenda to end the more than 30-year-old epidemic. The report has been released on the eve of World AIDS Day.

    November 29, 2011
    Voice of America